MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
Tang R, Xu X, Yang W, Yu W, Hou S, Xuan Y, Tang Z, Zhao S, Chen Y, Xiao X, Huang W, Guo W, Li M, Deng W.
Tang R, et al. Among authors: xu x.
Cancer Lett. 2016 Apr 1;373(1):77-87. doi: 10.1016/j.canlet.2016.01.005. Epub 2016 Jan 18.
Cancer Lett. 2016.
PMID: 26797421